GEFITIN®
Product characteristics
Active substance: Gefitinib
Therapeutic group: Antineoplastic and immunomodulatory drugs. Antineoplastic drugs. Protein kinase inhibitors. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Gefitinib. ATC code L01ХЕ02
Form: 10 tablets in a blister pack. 3 blister packs in a cardboard box.
Package Type: Film-coated tablets, 250 mg
Download instruction